Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Smoking and schizophrenia (CROSBI ID 155911)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Šagud, Marina ; Mihaljević-Peleš, Alma ; Muck-Šeler, Dorotea ; Pivac, Nela ; Vuksan-Ćusa, Bjanka ; Jakovljević, Miro Smoking and schizophrenia // Psychiatria Danubina, 21 (2009), 3; 371-375

Podaci o odgovornosti

Šagud, Marina ; Mihaljević-Peleš, Alma ; Muck-Šeler, Dorotea ; Pivac, Nela ; Vuksan-Ćusa, Bjanka ; Jakovljević, Miro

engleski

Smoking and schizophrenia

A large number of worldwide studies describing current smoking in schizophrenia consistently suggest that schizophrenic patients from all countries share a common biological factor, that makes them more prone to smoke (De Leon and Diaz, 2005). There is also evidence that cigarette smoking can reduce deficits relative to dopamine hypofunction in prefrontal cortex. All these data suggest that clinicians should consider smoking as an important factor in the disposition of these drugs. Namely, schizophrenic patients who smoke may require higher dosages of antipsychotics than nonsmokers. Conversely, upon smoking cessation, smokers may require a reduction in the dosage of antipsychotics.

cigarette smoking; schizophrenia; nicotine addiction

Rad je prezentiran na skupu.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

21 (3)

2009.

371-375

objavljeno

0353-5053

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti

Poveznice
Indeksiranost